We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Assessment reveals immunoreactive affinity of the antibody-radionuclide conjugate, suggesting potential therapeutic applications.
Immunoreactive affinity of antibody-radionuclide conjugate (ARC).
No takes yet. Share an insight, caveat, or question.
Lindland et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: